Behavioral Program for Weight Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand why some people hit a weight loss plateau, even with continued efforts to lose weight. Participants will join a Behavioral Weight Loss Program to examine how changes in metabolism or brain activity might influence this plateau. The trial seeks individuals with a BMI between 30 and 50 who live independently and can attend classes and study visits. Non-smokers who do not use drugs heavily and have not experienced certain medical conditions like diabetes or a stroke may be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on weight loss challenges.
Will I have to stop taking my current medications?
The trial requires that you stop taking medications that significantly affect appetite, such as weight loss medications, atypical antipsychotics, and stimulants, as well as chronic use of anticoagulants.
What prior data suggests that this behavioral weight loss program is safe?
Research has shown that behavioral weight loss programs are generally safe and easy to follow. These programs emphasize healthy lifestyle changes, such as diet and exercise, while avoiding risky weight-loss methods.
For example, intensive behavioral therapy for obesity has proven effective in helping people lose weight safely. This method supports gradual and safe weight loss. Studies also indicate that these programs help maintain weight loss by promoting ongoing healthy habits.
Overall, evidence suggests that joining a behavioral weight loss program is a safe choice for those seeking to lose weight through lifestyle changes.12345Why are researchers excited about this trial?
Researchers are excited about the Behavioral Weight Loss Program because it emphasizes changing daily habits and behaviors, which is different from traditional treatments like medications or surgery. This approach focuses on sustainable lifestyle changes, potentially offering long-term weight management without the side effects associated with pharmaceuticals. Additionally, the program encourages personal empowerment and self-monitoring, which can lead to better adherence and improved outcomes compared to more passive treatments.
What evidence suggests that this behavioral weight loss program is effective for obesity?
Research has shown that programs focused on changing behavior can help people lose weight effectively. Participants in the Behavioral Weight Loss Program, the focus of this trial, often lose about 8–10 kg, or around 8–10% of their starting weight. Studies have found that these programs help maintain weight loss over time. Intensive behavioral therapy, which emphasizes healthy eating and regular exercise, works well without involving any risky methods. Overall, these programs offer a reliable and proven way to lose weight and maintain it.46789
Who Is on the Research Team?
Ellen Schur, MD, MS
Principal Investigator
University of Washington
Marian L. Neuhouser
Principal Investigator
Fred Hutch Cancer Center
Are You a Good Fit for This Trial?
This trial is for individuals who are experiencing obesity and want to lose weight. Participants should be willing to follow a Behavioral Weight Loss Program but have hit an involuntary weight loss plateau despite their efforts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Study Visits
Participants complete 3 in-person study visits for baseline assessments including questionnaires, blood draws, brain MRIs, body measurements, DXA scans, breathing tests, and biopsies.
Weight Loss Program
Participants undergo a 6-month behavioral weight loss program delivered remotely.
Additional Study Visits
Some participants may be invited to complete 3 additional in-person visits for further assessments.
Follow-up
Participants are monitored for physiological changes and weight loss plateau occurrence.
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Weight Loss Program
Behavioral Weight Loss Program is already approved in United States, European Union for the following indications:
- Obesity
- Weight Loss
- Type 2 Diabetes Prevention
- Obesity
- Weight Loss
- Type 2 Diabetes Prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator